Document is current
Any future updates will be listed below
-
Authors
Goldufsky, Josef W.
Daniels, Preston
Williams, Michael D.
Gupta, Kajal
Lyday, Bruce
Chen, Tony
Singh, Geeta
Kaufman, Howard L.
Zloza, Andrew
Marzo, Amanda L.
- License Information
-
More Information
Article History
Received: 26 January 2023
Accepted: 11 July 2023
First Online: 19 July 2023
Declarations
:
: Written informed consent was obtained from all participants. Acquisition of tissue samples was approved by the IRB of Rush University Medical Center.
: Not applicable.
: BL and TC are inventors on patent applications related to PV001-DV. BL, TC, and GS are employees of Primevax Immuno-Oncology, Inc. BL, TC, GS, and AZ hold equity in Primevax Immuno-Oncology, Inc. HLK is an employee of Ankyra Therapeutics and has served on advisory boards for Castle Biosciences, Marengo Therapeutics and Virogin.
